AUSTRAL Dx is developing a new imaging technique based on airborne ultrasounds in order to map the vibrations coming from the lungs.
AUSTRAL Dx has raised $1.1M in total funding. The most recent round was Seed. The last funding was announced in July 2025.
AUSTRAL Dx's investors include Bpifrance, Kima Ventures, Super Capital VC, Better Angle, AGORANOV.
AUSTRAL Dx is headquartered in Paris, France.
AUSTRAL Dx is developing a new imaging technique based on airborne ultrasounds in order to map the vibrations coming from the lungs.
AUSTRAL Dx is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"AUSTRAL Dx — Funding & Investors." VCBacked, July 24, 2025, https://www.vcbacked.co/company/austral-dx. Accessed October 17, 2026.
VCBacked. (2025). AUSTRAL Dx — Funding & Investors. Retrieved October 17, 2026, from https://www.vcbacked.co/company/austral-dx
{{cite web |title=AUSTRAL Dx — Funding & Investors |url=https://www.vcbacked.co/company/austral-dx |website=VCBacked |access-date=October 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated